The mechanism by which spinal cord injury (SCI) induces neuronal death has not been thoroughly understood. Investigation on the molecular signal pathways involved in SCI-mediated neuronal apoptosis is important for development of new therapeutics for SCI. In the current study, we explore the role of heme oxygenase-1 (HO-1) in the modulation of mixed lineage kinase 3/mitogen-activated protein kinase kinase/cJUN N-terminal kinase 3 (MLK3/MKK7/JNK3) signaling, which is a pro-apoptotic pathway, after SCI. We found that MLK3/MKK7/JNK3 signaling was activated by SCI in a time-dependent manner, demonstrated by increase in activating phosphorylation of MLK3, MKK7, and JNK3. SCI also induced HO-1 expression. Administration of HO-1-expressing adeno-associated virus before SCI introduced expression of exogenous HO-1 in injured spinal cords. Exogenous HO-1 reduced phosphorylation of MLK3, MKK7, and JNK3. Consistent with its inhibitory effect on MLK3/MKK7/JNK3 signaling, exogenous HO-1 decreased SCI-induced neuronal apoptosis and improved neurological score. Further, we found that exogenous HO-1 inhibited expression of cell division cycle 42 (Cdc42), which is crucial for MLK3 activation. In vitro experiments indicated that Cdc42 was essential for neuronal apoptosis, while transduction of neurons with HO-1-expressing adeno-associated virus significantly reduced neuronal apoptosis to enhance neuronal survival. Therefore, our study disclosed a novel mechanism by which HO-1 exerted its neuroprotective efficacy. Our discovery might be valuable for developing a new therapeutic approach for SCI.
Get full access to this article
View all access options for this article.
References
1.
SilvaN.A., SousaN., ReisR.L., and SalgadoA.J. (2014). From basics to clinical: a comprehensive review on spinal cord injury. Prog. Neurobiol., 114, 25–57.
2.
CramerS.C., LastraL., LacourseM.G., and CohenM.J. (2005). Brain motor system function after chronic, complete spinal cord injury. Brain, 128, 2941–2950.
3.
YiuG., and HeZ. (2006). Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci., 7, 617–627.
4.
ToborekM., MaleckiA., GarridoR., MattsonM.P., HennigB., and YoungB. (1999). Arachidonic acid-induced oxidative injury to cultured spinal cord neurons. J. Neurochem., 73, 684–692.
5.
JammeI., PetitE., DivouxD., GerbiA., MaixentJ.M., and NouvelotA. (1995). Modulation of mouse cerebral Na+,K(+)-ATPase activity by oxygen free radicals. Neuroreport, 7, 333–337.
6.
ZhangN., YinY., XuS.J., WuY.P., and ChenW.S. (2012). Inflammation & apoptosis in spinal cord injury. Indian J. Med. Res., 135, 287–296.
7.
BeattieM.S. (2004). Inflammation and apoptosis: linked therapeutic targets in spinal cord injury. Trends Mol. Med., 10, 580–583.
8.
WangR., ZhangQ.G., HanD., XuJ., LuQ., and ZhangG.Y. (2006). Inhibition of MLK3-MKK4/7-JNK1/2 pathway by Akt1 in exogenous estrogen-induced neuroprotection against transient global cerebral ischemia by a non-genomic mechanism in male rats. J. Neurochem., 99, 1543–1554.
9.
TournierC., DongC., TurnerT.K., JonesS.N., FlavellR.A., and DavisR.J. (2001). MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev. 15, 1419–1426.
10.
DhanasekaranD.N., and ReddyE.P. (2008). JNK signaling in apoptosis. Oncogene, 27, 6245–6251.
11.
ChoiW.S., KlintworthH.M., and XiaZ. (2011). JNK3-mediated apoptotic cell death in primary dopaminergic neurons. Methods Mol. Biol., 758, 279–292.
12.
XieX., GuY., FoxT., CollJ.T., FlemingM.A., MarklandW., CaronP.R., WilsonK.P., and SuM.S. (1998). Crystal structure of JNK3: a kinase implicated in neuronal apoptosis. Structure, 6, 983–991.
13.
PaineA., Eiz-VesperB., BlasczykR., and ImmenschuhS. (2010). Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem. Pharmacol., 80, 1895–1903.
14.
MancusoC., and BaroneE. (2009). The heme oxygenase/biliverdin reductase pathway in drug research and development. Curr. Drug Metab., 10, 579–594.
15.
RajuV.S., McCoubreyW.K.Jr., and MainesM.D. (1997). Regulation of heme oxygenase-2 by glucocorticoids in neonatal rat brain: characterization of a functional glucocorticoid response element. Biochim. Biophys. Acta, 1351, 89–104.
16.
MainesM.D. (1997). The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol., 37, 517–554.
17.
OkinagaS., TakahashiK., TakedaK., YoshizawaM., FujitaH., SasakiH., and ShibaharaS. (1996). Regulation of human heme oxygenase-1 gene expression under thermal stress. Blood, 87, 5074–5084.
18.
CantoniL., RossiC., RizzardiniM., GadinaM., and GhezziP. (1991). Interleukin-1 and tumour necrosis factor induce hepatic haem oxygenase. Feedback regulation by glucocorticoids. Biochem. J., 279, 891–894.
19.
GozzelinoR., JeneyV., and SoaresM.P. (2010). Mechanisms of cell protection by heme oxygenase-1. Annu. Rev. Pharmacol. Toxicol., 50, 323–354.
20.
MancusoC., PreziosiP., GrossmanA.B., and NavarraP. (1997). The role of carbon monoxide in the regulation of neuroendocrine function. Neuroimmunomodulation, 4, 225–229.
21.
MancusoC., RagazzoniE., TringaliG., LiberaleI., PreziosiP., GrossmanA., and NavarraP. (1999). Inhibition of heme oxygenase in the central nervous system potentiates endotoxin-induced vasopressin release in the rat. J. Neuroimmunol., 99, 189–194.
22.
PanahianN., and MainesM.D. (2001). Site of injury-directed induction of heme oxygenase-1 and −2 in experimental spinal cord injury: differential functions in neuronal defense mechanisms?. J. Neurochem., 76, 539–554.
23.
YamadaK., TanakaN., NakanishiK., KameiN., IshikawaM., MizunoT., IgarashiK., and OchiM. (2008). Modulation of the secondary injury process after spinal cord injury in Bach1-deficient mice by heme oxygenase-1. J. Neurosurg. Spine, 9, 611–620.
24.
LinY., VremanH.J., WongR.J., TjoaT., YamauchiT., and Noble-HaeussleinL.J. (2007). Heme oxygenase-1 stabilizes the blood-spinal cord barrier and limits oxidative stress and white matter damage in the acutely injured murine spinal cord. J. Cereb. Blood Flow Metab., 27, 1010–1021.
25.
LinW.P., XiongG.P., LinQ., ChenX.W., ZhangL.Q., ShiJ.X., KeQ.F., and LinJ.H. (2016). Heme oxygenase-1 promotes neuron survival through down-regulation of neuronal NLRP1 expression after spinal cord injury. J. Neuroinflammation, 13, 52.
26.
SongY.J., ZongZ.M., LiuH.Z., MukasaR., PeiD.S., MouJ., WenX.R., LiuZ.A., and WeiX.Y. (2012). Heme oxygenase-1 regulates the JNK signaling pathway through the MLK3-MKK7-JNK3 signaling module in brain ischemia injury. Brain Res. 1429, 1–8.
27.
HallJ.C., PriestleyJ.V., PerryV.H., and Michael-TitusA.T. (2012). Docosahexaenoic acid, but not eicosapentaenoic acid, reduces the early inflammatory response following compression spinal cord injury in the rat. J. Neurochem., 121, 738–750.
28.
KehlL.J., FairbanksC.A., LaughlinT.M., and WilcoxG.L. (1997). Neurogenesis in postnatal rat spinal cord: a study in primary culture. Science, 276, 586–589.
29.
AndersonK.N., PotterA.C., PiccennaL.G., QuahA.K., DaviesK.E., and CheemaS.S. (2004). Isolation and culture of motor neurons from the newborn mouse spinal cord. Brain Res. Brain Res. Protoc., 12, 132–136.
30.
BassoD.M., BeattieM.S., and BresnahanJ.C. (1995). A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma, 12, 1–21.
31.
DuY., BockB.C., SchachterK.A., ChaoM., and GalloK.A. (2005). Cdc42 induces activation loop phosphorylation and membrane targeting of mixed lineage kinase 3. J. Biol. Chem., 280, 42984–42993.
32.
LawlerS., FlemingY., GoedertM., and CohenP. (1998). Synergistic activation of SAPK1/JNK1 by two MAP kinase kinases in vitro. Curr. Biol., 8, 1387–1390.
33.
KishimotoH., NakagawaK., WatanabeT., KitagawaD., MomoseH., SeoJ., NishitaiG., ShimizuN., OhataS., TanemuraS., AsakaS., GotoT., FukushiH., YoshidaH., SuzukiA., SasakiT., WadaT., PenningerJ.M., NishinaH., and KatadaT. (2003). Different properties of SEK1 and MKK7 in dual phosphorylation of stress-induced activated protein kinase SAPK/JNK in embryonic stem cells. J Biol Chem, 278, 16595–16601.
34.
CuevasB.D., AbellA.N., and JohnsonG.L. (2007). Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene, 26, 3159–3171.
35.
YamasakiT., KawasakiH., and NishinaH. (2012). Diverse roles of JNK and MKK pathways in the brain. J. Signal Transduct. 2012, 459265.
36.
KuanC.Y., WhitmarshA.J., YangD.D., LiaoG., SchloemerA.J., DongC., BaoJ., BanasiakK.J., HaddadG.G., FlavellR.A., DavisR.J., and RakicP. (2003). A critical role of neural-specific JNK3 for ischemic apoptosis. Proc. Natl. Acad. Sci. U. S. A., 100, 15184–15189.
37.
LongJ., CaiL., LiJ., ZhangL., YangH., and WangT. (2013). JNK3 involvement in nerve cell apoptosis and neurofunctional recovery after traumatic brain injury. Neural Regen. Res., 8, 1491–1499.
38.
PanJ., LiH., ZhangB., XiongR., ZhangY., KangW.Y., ChenW., ZhaoZ.B., and ChenS.D. (2015). Small peptide inhibitor of JNK3 protects dopaminergic neurons from MPTP induced injury via inhibiting the ASK1-JNK3 signaling pathway. PLoS One, 10, e0119204.
39.
IchijoH., NishidaE., IrieK., ten DijkeP., SaitohM., MoriguchiT., TakagiM., MatsumotoK., MiyazonoK., and GotohY. (1997). Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science, 275, 90–94.
40.
ZhangT.L., FuJ.L., GengZ., YangJ.J. and SunX.J. (2012). The neuroprotective effect of losartan through inhibiting AT1/ASK1/MKK4/JNK3 pathway following cerebral I/R in rat hippocampal CA1 region. CNS Neurosci. Ther., 18, 981–987.
41.
LisnockJ., GriffinP., CalaycayJ., FrantzB., ParsonsJ., O,’KeefeS.J,. and LoGrassoP. (2000). Activation of JNK3 alpha 1 requires both MKK4 and MKK7: kinetic characterization of in vitro phosphorylated JNK3 alpha 1. Biochemistry, 39, 3141–3148.
42.
ByrnesK.R., StoicaB.A., FrickeS., Di GiovanniS., and FadenA.I. (2007). Cell cycle activation contributes to post-mitotic cell death and secondary damage after spinal cord injury. Brain, 130, 2977–2992.
43.
MizunoY., MochizukiH., SugitaY., and GotoK. (1998). Apoptosis in neurodegenerative disorders. Intern. Med., 37, 192–193.
44.
KeaneR.W., KraydiehS., LotockiG., BetheaJ.R., KrajewskiS., ReedJ.C., and DietrichW.D. (2001). Apoptotic and anti-apoptotic mechanisms following spinal cord injury. J. Neuropathol. Exp. Neurol., 60, 422–429.
45.
TakagiT., TakayasuM., MizunoM., YoshimotoM., and YoshidaJ. (2003). Caspase activation in neuronal and glial apoptosis following spinal cord injury in mice. Neurol. Med. Chir. (Tokyo) 43, 20–30.
46.
Le-NiculescuH., BonfocoE., KasuyaY., ClaretF.X., GreenD.R. and KarinM. (1999). Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol. Cell Biol., 19, 751–763.
47.
ZhangJ., GaoJ.X., SalojinK., ShaoQ., GrattanM., MeagherC., LairdD.W., and DelovitchT.L. (2000). Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase. J. Exp. Med., 191, 1017–1030.
48.
LeiK., and DavisR.J. (2003). JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc. Natl. Acad. Sci. U. S. A., 100, 2432–2437.
49.
PrauseM., ChristensenD.P., BillestrupN., and Mandrup-PoulsenT. (2014). JNK1 protects against glucolipotoxicity-mediated beta-cell apoptosis. PLoS One, 9, e87067.
50.
LiuJ., and LinA. (2005). Role of JNK activation in apoptosis: a double-edged sword. Cell Res. 15, 36–42.
51.
ChoiA.M., and AlamJ. (1996). Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am. J. Respir. Cell Mol. Biol., 15, 9–19.
52.
PalozzaP., SeriniS., CurroD., CalvielloG., IgarashiK., and MancusoC. (2006). beta-Carotene and cigarette smoke condensate regulate heme oxygenase-1 and its repressor factor Bach1: relationship with cell growth. Antioxid. Redox. Signal., 8, 1069–1080.
53.
YanoY., OzonoR., OishiY., KambeM., YoshizumiM., IshidaT., OmuraS., OshimaT., and IgarashiK. (2006). Genetic ablation of the transcription repressor Bach1 leads to myocardial protection against ischemia/reperfusion in mice. Genes Cells, 11, 791–803.
54.
KannoH., OzawaH., DohiY., SekiguchiA., IgarashiK., and ItoiE. (2009). Genetic ablation of transcription repressor Bach1 reduces neural tissue damage and improves locomotor function after spinal cord injury in mice. J. Neurotrauma, 26, 31–39.
55.
Perez-de-PuigI., MartinA., GorinaR., de la RosaX., MartinezE., and PlanasA.M. (2013). Induction of hemeoxygenase-1 expression after inhibition of hemeoxygenase activity promotes inflammation and worsens ischemic brain damage in mice. Neuroscience, 243, 22–32.
56.
XiaoweiH., NinghuiZ., WeiX., YipingT., and LinfengX. (2006). The experimental study of hypoxia-inducible factor-1alpha and its target genes in spinal cord injury. Spinal Cord, 44, 35–43.
57.
FlorczykU., CzaudernaS., StachurskaA., TertilM., NowakW., KozakowskaM., PoellingerL., JozkowiczA., LobodaA. and DulakJ. (2011). Opposite effects of HIF-1alpha and HIF-2alpha on the regulation of IL-8 expression in endothelial cells. Free Radic. Biol. Med., 51, 1882–1892.
58.
LobodaA., StachurskaA., FlorczykU., RudnickaD., JazwaA., WegrzynJ., KozakowskaM., StalinskaK., PoellingerL., LevonenA.L., Yla-HerttualaS., JozkowiczA., and DulakJ. (2009). HIF-1 induction attenuates Nrf2-dependent IL-8 expression in human endothelial cells. Antioxid. Redox. Signal., 11, 1501–1517.
59.
ErschbamerM.K., HofstetterC.P., and OlsonL. (2005). RhoA, RhoB, RhoC, Rac1, Cdc42, and Tc10 mRNA levels in spinal cord, sensory ganglia, and corticospinal tract neurons and long-lasting specific changes following spinal cord injury. J. Comp. Neurol., 484, 224–233.
60.
ZhaoJ., PeiD.S., ZhangQ.G., and ZhangG.Y. (2007). Down-regulation Cdc42 attenuates neuronal apoptosis through inhibiting MLK3/JNK3 cascade during ischemic reperfusion in rat hippocampus. Cell Signal. 19, 831–843.
61.
TeramotoH., CosoO.A., MiyataH., IgishiT., MikiT., and GutkindJ.S. (1996). Signaling from the small GTP-binding proteins Rac1 and Cdc42 to the c-Jun N-terminal kinase/stress-activated protein kinase pathway. A role for mixed lineage kinase 3/protein-tyrosine kinase 1, a novel member of the mixed lineage kinase family. J. Biol. Chem., 271, 27225–27228.
62.
BockB.C., VacratsisP.O., QamiraniE., and GalloK.A. (2000). Cdc42-induced activation of the mixed-lineage kinase SPRK in vivo. Requirement of the Cdc42/Rac interactive binding motif and changes in phosphorylation. J. Biol. Chem., 275, 14231–14241.
63.
MotaM., ReederM., ChernoffJ., and BazenetC.E. (2001). Evidence for a role of mixed lineage kinases in neuronal apoptosis. J. Neurosci., 21, 4949–4957.
64.
JainA., McKeonR.J., Brady-KalnayS.M., and BellamkondaR.V. (2011). Sustained delivery of activated Rho GTPases and BDNF promotes axon growth in CSPG-rich regions following spinal cord injury. PLoS One, 6, e16135.
65.
ThreadgillR., BobbK., and GhoshA. (1997). Regulation of dendritic growth and remodeling by Rho, Rac, and Cdc42. Neuron, 19, 625–634.
66.
Al-HuseiniL.M., Aw YeangH.X., HamdamJ.M., SethuS., AlhumeedN., WongW., and SathishJ.G. (2014). Heme oxygenase-1 regulates dendritic cell function through modulation of p38 MAPK-CREB/ATF1 signaling. J. Biol. Chem., 289, 16442–16451.
67.
QiaoL.Y., and VizzardM.A. (2005). Spinal cord injury-induced expression of TrkA, TrkB, phosphorylated CREB, and c-Jun in rat lumbosacral dorsal root ganglia. J. Comp. Neurol., 482, 142–154.
68.
LinS.H., SongW., CressattiM., ZukorH., WangE.. and SchipperH.M. (2015). Heme oxygenase-1 modulates microRNA expression in cultured astroglia: implications for chronic brain disorders. Glia, 63, 1270–1284.
69.
SkrzypekK., TertilM., GoldaS., CieslaM., WeglarczykK., ColletG., GuichardA., KozakowskaM., BoczkowskiJ., WasH., GilT., KuzdzalJ., MuchovaL., VitekL., LobodaA., JozkowiczA., KiedaC., and DulakJ. (2013). Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis. Antioxid. Redox. Signal., 19, 644–660.
WeitzS.H., GongM., BarrI., WeissS., and GuoF. (2014). Processing of microRNA primary transcripts requires heme in mammalian cells. Proc. Natl. Acad. Sci. U. S. A., 111, 1861–1866.
